HCAT
Price
$3.24
Change
-$0.16 (-4.71%)
Updated
Sep 3 closing price
Capitalization
227.31M
68 days until earnings call
PHR
Price
$30.44
Change
-$1.04 (-3.30%)
Updated
Sep 3 closing price
Capitalization
1.81B
Earnings call today
Interact to see
Advertisement

HCAT vs PHR

Header iconHCAT vs PHR Comparison
Open Charts HCAT vs PHRBanner chart's image
Health Catalyst
Price$3.24
Change-$0.16 (-4.71%)
Volume$1.07M
Capitalization227.31M
Phreesia
Price$30.44
Change-$1.04 (-3.30%)
Volume$1.09M
Capitalization1.81B
HCAT vs PHR Comparison Chart in %
Loading...
HCAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HCAT vs. PHR commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCAT is a Hold and PHR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (HCAT: $3.40 vs. PHR: $31.48)
Brand notoriety: HCAT and PHR are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: HCAT: 144% vs. PHR: 134%
Market capitalization -- HCAT: $227.31M vs. PHR: $1.81B
HCAT [@Services to the Health Industry] is valued at $227.31M. PHR’s [@Services to the Health Industry] market capitalization is $1.81B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $44.41B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HCAT’s FA Score shows that 1 FA rating(s) are green whilePHR’s FA Score has 0 green FA rating(s).

  • HCAT’s FA Score: 1 green, 4 red.
  • PHR’s FA Score: 0 green, 5 red.
According to our system of comparison, PHR is a better buy in the long-term than HCAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HCAT’s TA Score shows that 4 TA indicator(s) are bullish while PHR’s TA Score has 6 bullish TA indicator(s).

  • HCAT’s TA Score: 4 bullish, 6 bearish.
  • PHR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PHR is a better buy in the short-term than HCAT.

Price Growth

HCAT (@Services to the Health Industry) experienced а -2.86% price change this week, while PHR (@Services to the Health Industry) price change was +2.21% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -0.23%. For the same industry, the average monthly price growth was +9.63%, and the average quarterly price growth was +20.57%.

Reported Earning Dates

HCAT is expected to report earnings on Nov 11, 2025.

PHR is expected to report earnings on Sep 04, 2025.

Industries' Descriptions

@Services to the Health Industry (-0.23% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHR($1.81B) has a higher market cap than HCAT($227M). PHR YTD gains are higher at: 25.119 vs. HCAT (-51.909). PHR has higher annual earnings (EBITDA): -9.46M vs. HCAT (-27.89M). HCAT has more cash in the bank: 97.3M vs. PHR (90.9M). PHR has less debt than HCAT: PHR (15.9M) vs HCAT (173M). PHR has higher revenues than HCAT: PHR (435M) vs HCAT (316M).
HCATPHRHCAT / PHR
Capitalization227M1.81B13%
EBITDA-27.89M-9.46M295%
Gain YTD-51.90925.119-207%
P/E RatioN/AN/A-
Revenue316M435M73%
Total Cash97.3M90.9M107%
Total Debt173M15.9M1,088%
FUNDAMENTALS RATINGS
HCAT vs PHR: Fundamental Ratings
HCAT
PHR
OUTLOOK RATING
1..100
722
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
45
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
8642
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCAT's Valuation (28) in the null industry is in the same range as PHR (45). This means that HCAT’s stock grew similarly to PHR’s over the last 12 months.

PHR's Profit vs Risk Rating (98) in the null industry is in the same range as HCAT (100). This means that PHR’s stock grew similarly to HCAT’s over the last 12 months.

PHR's SMR Rating (95) in the null industry is in the same range as HCAT (97). This means that PHR’s stock grew similarly to HCAT’s over the last 12 months.

PHR's Price Growth Rating (42) in the null industry is somewhat better than the same rating for HCAT (86). This means that PHR’s stock grew somewhat faster than HCAT’s over the last 12 months.

PHR's P/E Growth Rating (100) in the null industry is in the same range as HCAT (100). This means that PHR’s stock grew similarly to HCAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HCATPHR
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
71%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HCAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOSUY17.50N/A
N/A
Fosun International, Ltd.
JDWPF9.47N/A
N/A
J.D. Wetherspoon PLC
AHODF39.50N/A
N/A
Koninklijke Ahold Delhaize N.V.
ERVFF0.03N/A
-1.90%
Boron One Holdings Inc.
GENTF8.90-0.40
-4.30%
G5 Entertainment AB

HCAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCAT
1D Price
Change %
HCAT100%
+0.29%
KVYO - HCAT
47%
Loosely correlated
-5.21%
EVCM - HCAT
46%
Loosely correlated
-2.51%
CSGS - HCAT
45%
Loosely correlated
+0.58%
RDVT - HCAT
45%
Loosely correlated
-0.50%
PHR - HCAT
45%
Loosely correlated
-0.57%
More

PHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHR has been loosely correlated with QTWO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PHR jumps, then QTWO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHR
1D Price
Change %
PHR100%
-0.57%
QTWO - PHR
49%
Loosely correlated
-2.54%
QLYS - PHR
49%
Loosely correlated
-1.50%
DJCO - PHR
46%
Loosely correlated
+2.02%
ONTF - PHR
46%
Loosely correlated
-2.80%
ADSK - PHR
46%
Loosely correlated
+1.42%
More